Back to search
Infant Growth
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infant Growth trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infant Growth trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The researchers will study how babies respond to bottle nipples with different flow rates over a few days, and how this may affect how much milk they drink, the…
This is a Phase 2, multicenter, randomized, placebo-controlled study to evaluate the safety and efficacy of infigratinib in participants \< 3 years old with ACH…
Randomized, controlled study consisting of three parallel arms to investigate the effects of novel infant formula on growth, gut health, immune function, and sl…
Growth-restricted very preterm infants (VPT) are born without adequate fat mass (FM) deposits and low docosahexaenoic acid (DHA) concentrations. They often expe…
The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body…
The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two in…
The central hypothesis of this clinical trial is that, in extremely preterm infants, protein-enriched human milk diets compared to usual human milk diets during…
Late preterm infants, who are born at 34, 35 or 36 weeks gestation, often have difficulty feeding, establishing growth, and fighting off infection. Breastfeedin…